{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:33:29Z","timestamp":1790040809565,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004562","name":"French Ministry of Health, Programme Hospitalier de Recherche Clinique 2001","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soutien aux Technologies Innovantes, STIC 2006"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.therap.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:37:32Z","timestamp":1581593852000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome"],"prefix":"10.1016","volume":"75","author":[{"given":"Pierre","family":"Boutouyrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1, SI","key":"10.1016\/j.therap.2020.02.009_bib0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31553","article-title":"Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome","volume":"175","author":"Byers","year":"2017","journal-title":"Am J Med Genet PART C Semin Med Genet"},{"issue":"5","key":"10.1016\/j.therap.2020.02.009_bib0140","first-page":"530","article-title":"Status dysvascularis","volume":"196","author":"Strauss","year":"1949","journal-title":"Dtsch Arch Klin Med"},{"issue":"2","key":"10.1016\/j.therap.2020.02.009_bib0145","first-page":"160","article-title":"Vascular complications in Ehlers-Danlos syndrome\u00a0\u2013\u00a0with special reference to arterial type or Sacks syndrome","volume":"13","author":"Barabas","year":"1972","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"1","key":"10.1016\/j.therap.2020.02.009_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O","article-title":"Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997","volume":"77","author":"Beighton","year":"1998","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.therap.2020.02.009_bib0155","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1073\/pnas.72.4.1314","article-title":"Patients with Ehlers-Danlos syndrome type-IV lack type-III collagen","volume":"72","author":"Pope","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.therap.2020.02.009_bib0160","first-page":"A512","article-title":"Altered secretion of type-3\u00a0collagen in a form of type-4\u00a0Ehlers-Danlos syndrome (EDS)","volume":"26","author":"Byers","year":"1978","journal-title":"Clin Res"},{"issue":"13","key":"10.1016\/j.therap.2020.02.009_bib0165","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1016\/S0021-9258(18)68776-9","article-title":"Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1\u00a0alleles affecting structure, stability, and processing of type III procollagen","volume":"263","author":"Superti-Furga","year":"1988","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.therap.2020.02.009_bib0170","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/ejhg.2015.32","article-title":"The type of variants at the COL3A1\u00a0gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome","volume":"23","author":"Frank","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.therap.2020.02.009_bib0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM200003093421001","article-title":"Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type","volume":"342","author":"Pepin","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.therap.2020.02.009_bib0180","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/gim.2014.72","article-title":"Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV)","volume":"16","author":"Pepin","year":"2014","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.therap.2020.02.009_bib0185","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.therap.2020.02.009_bib0190","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.20353","article-title":"Identification and in sillico analyses of novel TGFBR1\u00a0and TGFBR2\u00a0mutations in Marfan syndrome-related disorders","volume":"27","author":"M\u00e1ty\u00e1s","year":"2006","journal-title":"Hum Mutat"},{"issue":"16","key":"10.1016\/j.therap.2020.02.009_bib0195","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa002939","article-title":"A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency","volume":"345","author":"Schalkwijk","year":"2001","journal-title":"N Engl J Med"},{"issue":"9751","key":"10.1016\/j.therap.2020.02.009_bib0200","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial","volume":"376","author":"Ong","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.therap.2020.02.009_bib0205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/fcp.12314","article-title":"Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology","volume":"31","author":"Micallef","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.therap.2020.02.009_bib0210","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.0000121741.50315.C2","article-title":"Increased carotid wall stress in vascular Ehlers-Danlos syndrome","volume":"109","author":"Boutouyrie","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.therap.2020.02.009_bib0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.hjh.0000160212.33232.3e","article-title":"Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA)","volume":"23","author":"Giannattasio","year":"2005","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.therap.2020.02.009_bib0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/CRD.0000000000000159","article-title":"Celiprolol: a unique selective adrenoceptor modulator","volume":"25","author":"Nawarskas","year":"2017","journal-title":"Cardiol Rev"},{"issue":"22","key":"10.1016\/j.therap.2020.02.009_bib0225","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/01.CIR.101.22.2601","article-title":"Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment","volume":"101","author":"Boutouyrie","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.therap.2020.02.009_bib0230","first-page":"S15","article-title":"Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination","volume":"19","author":"Asmar","year":"2001","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.therap.2020.02.009_bib0235","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1073\/pnas.94.5.1852","article-title":"Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.therap.2020.02.009_bib0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/HYPERTENSIONAHA.111.00974","article-title":"Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1\u00a0haploinsufficient mice","volume":"62","author":"Faugeroux","year":"2013","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.therap.2020.02.009_bib0245","first-page":"457","article-title":"Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers\u2013Danlos syndrome","volume":"116","author":"Dubacher","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.therap.2020.02.009_bib0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1536\/ihj.16-094","article-title":"Pathophysiology and management of cardiovascular manifestations in Marfan and Loeys-Dietz syndromes","volume":"57","author":"Takeda","year":"2016","journal-title":"Int Heart J"},{"issue":"15","key":"10.1016\/j.therap.2020.02.009_bib0255","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jacc.2019.01.058","article-title":"Vascular Ehlers-Danlos syndrome long-term observational study","volume":"73","author":"Frank","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.therap.2020.02.009_bib0260","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720300147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595720300147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:44Z","timestamp":1758567224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595720300147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0040595720300147"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2020.02.009","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An old drug for a rare disease: The example of celiprolol for vascular Ehlers-Danlos syndrome","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}